title: Response to: 'Issues with anti-Gr1 antibody-mediated myeloid-derived suppressor cell depletion' by Xing et al.
authors.affiliation: Department of Human and Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA Institute of Molecular Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
authors.forename: Xiang-Yang
authors.initials: XY
authors.lastname: Wang
authors.affiliation: Institute of Immunology, The First Bethune Hospital Academy of Translational Medicine, Jilin University, Changchun, Jilin, China.
authors.forename: Huanfa
authors.initials: H
authors.lastname: Yi
authors.affiliation: Department of Rheumatology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China Department of Traditional Chinese Internal Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China.
authors.forename: Juan
authors.initials: J
authors.lastname: Li
mesh_terms: D039481:CD11b Antigen; D022423:Myeloid Cells; D000072737:Myeloid-Derived Suppressor Cells
chemical_list: D039481:CD11b Antigen
keywords: Autoimmune Diseases; Rheumatoid Arthritis; T Cells